OBJECTIVE: To examine the temporal relation between depression and cognitive impairment in old age. DESIGN: Prospective, population based study with four years of follow up. SETTING: City of Leiden, the Netherlands. PARTICIPANTS: 500 people aged 85 years at recruitment. MAIN OUTCOME MEASURES: Annual assessments of depressive symptoms (15 item geriatric depression scale), global cognitive function (mini-mental state examination), attention (Stroop test), processing speed (letter digit coding test), and immediate and delayed recall (12 word learning test). RESULTS: At 85 years old, participants' depressive symptoms and cognitive impairment were highly significantly correlated (P < 0.001). During follow up, an accelerated annual increase of depressive symptoms was associated with impaired attention (0.08 points (95% confidence interval 0.01 to 0.16)), immediate recall (0.17 points (0.09 to 0.25)), and delayed recall (0.10 points (0.02 to 0.18)) at baseline. In contrast, depressive symptoms at baseline were not related to an accelerated cognitive decline during follow up (P > 0.05). CONCLUSION: Caregivers should be aware of the development of depressive symptoms when cognitive impairment is present. However, the presence of depression only does not increase the risk of cognitive decline.
OBJECTIVE: To examine the temporal relation between depression and cognitive impairment in old age. DESIGN: Prospective, population based study with four years of follow up. SETTING: City of Leiden, the Netherlands. PARTICIPANTS: 500 people aged 85 years at recruitment. MAIN OUTCOME MEASURES: Annual assessments of depressive symptoms (15 item geriatric depression scale), global cognitive function (mini-mental state examination), attention (Stroop test), processing speed (letter digit coding test), and immediate and delayed recall (12 word learning test). RESULTS: At 85 years old, participants' depressive symptoms and cognitive impairment were highly significantly correlated (P < 0.001). During follow up, an accelerated annual increase of depressive symptoms was associated with impaired attention (0.08 points (95% confidence interval 0.01 to 0.16)), immediate recall (0.17 points (0.09 to 0.25)), and delayed recall (0.10 points (0.02 to 0.18)) at baseline. In contrast, depressive symptoms at baseline were not related to an accelerated cognitive decline during follow up (P > 0.05). CONCLUSION: Caregivers should be aware of the development of depressive symptoms when cognitive impairment is present. However, the presence of depression only does not increase the risk of cognitive decline.
Authors: Robert C Green; L Adrienne Cupples; Alex Kurz; Sanford Auerbach; Rodney Go; Dessa Sadovnick; Ranjan Duara; Walter A Kukull; Helena Chui; Timi Edeki; Patrick A Griffith; Robert P Friedland; David Bachman; Lindsay Farrer Journal: Arch Neurol Date: 2003-05
Authors: A S Henderson; A E Korten; P A Jacomb; A J Mackinnon; A F Jorm; H Christensen; B Rodgers Journal: Psychol Med Date: 1997-01 Impact factor: 7.723
Authors: David J Vinkers; Jacobijn Gussekloo; Max L Stek; Rudi G J Westendorp; Roos C Van Der Mast Journal: Int J Geriatr Psychiatry Date: 2004-01 Impact factor: 3.485
Authors: Sophie E Holmes; Irina Esterlis; Carolyn M Mazure; Yen Ying Lim; David Ames; Stephanie Rainey-Smith; Chris Fowler; Kathryn Ellis; Ralph N Martins; Olivier Salvado; Vincent Doré; Victor L Villemagne; Christopher C Rowe; Simon M Laws; Colin L Masters; Robert H Pietrzak; Paul Maruff Journal: Int J Geriatr Psychiatry Date: 2017-07-24 Impact factor: 3.485
Authors: Jon-Erik Cleophas Holty; Neeta Parimi; Michael Ballesteros; Terri Blackwell; Paul T Cirangle; Gregg H Jossart; Nicole D Kimbrough; Jennifer M Rose; Katie L Stone; Dena M Bravata Journal: Obes Surg Date: 2011-10 Impact factor: 4.129
Authors: Allison R Kaup; Amy L Byers; Cherie Falvey; Eleanor M Simonsick; Suzanne Satterfield; Hilsa N Ayonayon; Stephen F Smagula; Susan M Rubin; Kristine Yaffe Journal: JAMA Psychiatry Date: 2016-05-01 Impact factor: 21.596
Authors: Michael W Lutz; Ramon Casanova; Santiago Saldana; Maragatha Kuchibhatla; Brenda L Plassman; Kathleen M Hayden Journal: Neurobiol Aging Date: 2019-03-06 Impact factor: 4.673
Authors: Antonio Lobo; Raúl López-Antón; Concepción de-la-Cámara; Miguel Angel Quintanilla; Antonio Campayo; Pedro Saz Journal: Neurotox Res Date: 2008-10 Impact factor: 3.911